✦ LIBER ✦

Targeting the subtypes of breast cancer: rethinking investigational drugs

✍ Scribed by Curigliano, Giuseppe; Locatelli, Marzia; Fumagalli, Luca; Brollo, Janaina; Munzone, Elisabetta; Nolé, Franco; Criscitiello, Carmen; Goldhirsch, Aron

Book ID: 120260564
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 448 KB
Volume: 21
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543784.2012.651456

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New drugs for breast cancer subtypes: Ta

New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistance

✍ Giuseppe Curigliano 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Rethinking the development of breast can

Rethinking the development of breast cancer

✍ Schehr, Robert S. 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 618 KB

Rational combinations of siRNAs targetin

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

✍ Spänkuch, B; Kurunci-Csacsko, E; Kaufmann, M; Strebhardt, K 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 700 KB

Targeting IL-6 for the treatment of rheu

Targeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs

✍ Semerano, Luca; Thiolat, Allan; Minichiello, Emeline; Clavel, Gaëlle; Bessis, Na 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 573 KB

Mutation profiling identifies numerous r

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

✍ Libero Santarpia, Yuan Qi, Katherine Stemke-Hale, Bailiang Wang, Elliana J. Youn 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 354 KB

Potential molecular targeted therapies i

Potential molecular targeted therapies in the management of the basal-like subtype of breast cancer

✍ Mevlut Kurt; Hakan Harputluoglu; Didem S. Dede; Ibrahim H. Gullu; Kadri Altundag 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB